nach oben

HNO

Erschienen in:

12.01.2022 | Neurologische Beteiligung bei Infektionserkrankungen | CME Zur Zeit gratis

Riech- und Schmeckstörungen

verfasst von: Dr. med. M. M. Speth, U. S. Speth, A. R. Sedaghat, T. Hummel

Erschienen in: HNO | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Zusammenfassung

Ziel der vorliegenden Übersicht ist es, einen Überblick über die Ätiologie und Diagnostik von Riech- und Schmeckstörungen zu geben. Da etwa 5 % der Allgemeinbevölkerung betroffen sind, ist es ein häufiges Krankheitsbild. Riechen und Schmecken erhielten v. a. zuletzt Aufmerksamkeit während des Aufkommens der SARS-CoV-2-Pandemie, wobei eine plötzlich aufgetretene Riech- und/oder Schmeckstörung zu den typischen Symptomen zählt. Daneben sind Riechstörungen in der Frühdiagnostik neurodegenerativer Erkrankungen von Bedeutung. Häufig zeigen Patienten mit Riechstörungen Zeichen einer Depression. Die Auswirkungen von Riech‑/Schmeckstörungen sind also umfangreich, die Therapiemöglichkeiten aktuell begrenzt. Nach einem Einblick in die Ätiologie werden Diagnostik und Therapiemöglichkeiten auf dem aktuellen Stand der Literatur erörtert. Auch zukunftsweisende Behandlungsvorstellungen, wie z. B. autologe Schleimhauttransplantationen oder olfaktorische Implantate, werden angesprochen.

Fokkens WJ et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58(S29):1–464PubMed

Stogbauer J et al (2020) Prevalence and risk factors of smell dysfunction—a comparison between five German population-based studies. Rhinology 58(2):184–191PubMed

Landis BN, Hummel T (2006) New evidence for high occurrence of olfactory dysfunctions within the population. Am J Med 119(1):91–92PubMed

Hummel T, Frasnelli J (2019) The intranasal trigeminal system. Handb Clin Neurol 164:119–134PubMed

Hummel T et al (2017) Position paper on olfactory dysfunction. Rhinol Suppl 54(26):1–30PubMed

Hura N et al (2020) Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations. Int Forum Allergy Rhinol 10(9):1065–1086PubMed

Hatt H (2011) Geschmack und Geruch. In: Schmidt RF, Lang F, Heckmann M (Hrsg) Physiologie des Menschen: mit Pathophysiologie. Springer, Berlin, Heidelberg, S 386–400

Van Regemorter V et al (2020) Mechanisms linking olfactory impairment and risk of mortality. Front Neurosci 14:140PubMedPubMedCentral

Kohli P et al (2016) The association between olfaction and depression: a systematic review. Chem Senses 41(6):479–486PubMedPubMedCentral

10.

Pinto JM et al (2014) Olfactory dysfunction predicts 5‑year mortality in older adults. PLoS One 9(10):e107541PubMedPubMedCentral

11.

Drews T, Hummel T (2016) Treatment strategies for smell loss. Curr Otorhinolaryngol Rep 4(2):122–129

12.

Corwin J, Loury M, Gilbert AN (1995) Workplace, age, and sex as mediators of olfactory function: data from the national geographic smell survey. J Gerontol B Psychol Sci Soc Sci 50(4):P179–186PubMed

13.

Mascagni P et al (2003) Olfactory function in workers exposed to moderate airborne cadmium levels. Neurotoxicology 24(4–5):717–724PubMed

14.

Damm M et al (2004) Olfactory dysfunctions. Epidemiology and therapy in Germany, Austria and Switzerland. HNO 52(2):112–120PubMed

15.

Ogawa T, Rutka J (1999) Olfactory dysfunction in head injured workers. Acta Otolaryngol Suppl 540:50–57PubMed

16.

Haehner A et al (2007) Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Mov Disord 22(6):839–842PubMed

17.

Bernhardson BM, Tishelman C, Rutqvist LE (2007) Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. J Pain Symptom Manage 34(4):403–412PubMed

18.

Whitcroft KL, Hummel T (2019) Clinical diagnosis and current management strategies for olfactory dysfunction: a review. JAMA Otolaryngol Head Neck Surg 145(9):846–853PubMed

19.

Welge-Luessen A, Leopold DA, Miwa T (2013) Smell and taste disorders—diagnostic and clinical work-up. In: Welge-Luessen A, Hummel T (Hrsg) Management of smell and taste disorders—a practical guide for clinicians. Thieme, Stuttgart, S 49–57

20.

Poletti SC et al (2018) Olfactory cleft evaluation: a predictor for olfactory function in smell-impaired patients? Eur Arch Otorhinolaryngol 275(5):1129–1137PubMed

21.

Lötsch J, Hummel T (2019) Clinical usefulness of self-rated olfactory performance—a data science-based assessment of 6000 patients. Chem Senses 44(6):357–364PubMed

22.

Zou LQ et al (2020) Self-reported mini olfactory questionnaire (Self-MOQ): a simple and useful measurement for the screening of olfactory dysfunction. Laryngoscope 130(12):E786–e790PubMed

23.

Welge-Lussen A et al (2010) Olfactory testing in clinical settings—is there additional benefit from unilateral testing? Rhinology 48(2):156–159PubMed

24.

Walliczek-Dworschak U, Hummel T (2017) The human sense of olfaction. Facial Plast Surg 33(4):396–404PubMed

25.

Apter AJ, Gent JF, Frank ME (1999) Fluctuating olfactory sensitivity and distorted odor perception in allergic rhinitis. Arch Otolaryngol Head Neck Surg 125(9):1005–1010PubMed

26.

Landis BN, Hsieh JW, Coppin G (2018) Circadian anosmia: a rare clinical presentation. Laryngoscope 128(7):1537–1539PubMed

27.

Negoias S et al (2016) Rapidly fluctuating anosmia: a clinical sign for unilateral smell impairment. Laryngoscope 126(2):E57–9PubMed

28.

Seiden AM, Duncan HJ (2001) The diagnosis of a conductive olfactory loss. Laryngoscope 111(1):9–14PubMed

29.

Ganjaei KG et al (2018) Variability in retronasal odor identification among patients with chronic rhinosinusitis. Am J Rhinol Allergy 32(5):424–431PubMed

30.

Othieno F et al (2018) Retronasal olfaction in chronic rhinosinusitis. Laryngoscope 128(11):2437–2442PubMedPubMedCentral

31.

Landis BN et al (2003) Retronasal olfactory function in nasal polyposis. Laryngoscope 113(11):1993–1997PubMed

32.

Stevens MH (2001) Steroid-dependent anosmia. Laryngoscope 111(2):200–203PubMed

33.

Lane AP et al (2010) A genetic model of chronic rhinosinusitis-associated olfactory inflammation reveals reversible functional impairment and dramatic neuroepithelial reorganization. J Neurosci 30(6):2324–2329PubMedPubMedCentral

34.

Pfaar O et al (2006) Mechanical obstruction of the olfactory cleft reveals differences between orthonasal and retronasal olfactory functions. Chem Senses 31(1):27–31PubMed

35.

Aziz M et al (2021) The association of “loss of smell” to COVID-19: a systematic review and meta-analysis. Am J Med Sci 361(2):216–225PubMed

36.

Vaira LA et al (2020) Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope 130(7):1787PubMed

37.

Lechien JR et al (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 277(8):2251–2261PubMed

38.

Giacomelli A et al (2020) Self-reported olfactory and taste disorders in patients with severe acute respiratory Coronavirus 2 infection: a cross-sectional study. Clin Infect Dis 71(15):889–890PubMed

39.

Yan CH et al (2020) Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol 10(7):806–813PubMed

40.

Speth MM et al (2020) Olfactory dysfunction and sinonasal symptomatology in COVID-19: prevalence, severity, timing, and associated characteristics. Otolaryngol Head Neck Surg 163(1):114–120PubMedPubMedCentral

41.

Hopkins C et al (2020) Early recovery following new onset anosmia during the COVID-19 pandemic—an observational cohort study. J Otolaryngol Head Neck Surg 49(1):26PubMedPubMedCentral

42.

Hahner A, Hummel T, Stuck BA (2014) Olfactory disorders and their therapy. HNO 62(12):860–864 (866)PubMed

43.

Hummel T et al (2018) Olfactory training changes electrophysiological responses at the level of the olfactory epithelium. Rhinology 56(4):330–335PubMed

44.

Youngentob SL, Kent PF (1995) Enhancement of odorant-induced mucosal activity patterns in rats trained on an odorant identification task. Brain Res 670(1):82–88PubMed

45.

Negoias S, Pietsch K, Hummel T (2017) Changes in olfactory bulb volume following lateralized olfactory training. Brain Imaging Behav 11(4):998–1005PubMed

46.

Pellegrino R et al (2016) Olfactory function in patients with hyposmia compared to healthy subjects—an fMRI study. Rhinology 54(4):374–381PubMed

47.

Al Aïn S et al (2019) Smell training improves olfactory function and alters brain structure. Neuroimage 189:45–54PubMed

48.

Kollndorfer K et al (2014) Recovery of olfactory function induces neuroplasticity effects in patients with smell loss. Neural Plast 2014:140419PubMedPubMedCentral

49.

Hummel T, Welge-Luessen A (2009) Riech- und Schmeckstörungen. Physiologie, Pathophysiologie und therapeutische Ansätze. Thieme, Stuttgart

50.

Damm M et al (2014) Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study. Laryngoscope 124(4):826–831PubMed

51.

Altundag A et al (2015) Modified olfactory training in patients with postinfectious olfactory loss. Laryngoscope 125(8):1763–1766PubMed

52.

Sorokowska A et al (2017) Effects of olfactory training: a meta-analysis. Rhinology 55(1):17–26PubMed

53.

Mahmut MK et al (2020) The effect of olfactory training on olfactory bulb volumes in patients with idiopathic olfactory loss. Rhinology 58(4):410–412PubMed

54.

Saatci O et al (2020) Olfactory training ball improves adherence and olfactory outcomes in post-infectious olfactory dysfunction. Eur Arch Otorhinolaryngol 277(7):2125–2132PubMed

55.

Alanin MC, Hopkins C (2020) Effect of functional endoscopic sinus surgery on outcomes in chronic rhinosinusitis. Curr Allergy Asthma Rep 20(7):27PubMed

56.

Soler ZM et al (2016) Olfactory-specific quality of life outcomes after endoscopic sinus surgery. Int Forum Allergy Rhinol 6(4):407–413PubMed

57.

DeConde AS et al (2014) Comparative effectiveness of medical and surgical therapy on olfaction in chronic rhinosinusitis: a prospective, multi-institutional study. Int Forum Allergy Rhinol 4(9):725–733PubMedPubMedCentral

58.

Altun H, Hanci D (2015) Olfaction improvement after nasal septal perforation repair with the “cross-stealing” technique. Am J Rhinol Allergy 29(5):e142–145PubMed

59.

Philpott CM et al (2008) A study of olfactory testing in patients with rhinological pathology in the ENT clinic. Rhinology 46(1):34–39PubMed

60.

Leopold DA et al (1991) Successful treatment of phantosmia with preservation of olfaction. Arch Otolaryngol Head Neck Surg 117(12):1402–1406PubMed

61.

Shu CH et al (2012) Topical corticosteroids applied with a squirt system are more effective than a nasal spray for steroid-dependent olfactory impairment. Laryngoscope 122(4):747–750PubMed

62.

Damm M, Leung RM, Kern RC (2014) Sinonasal olfactory disorders. In: Welge-Luessen A, Hummel T (Hrsg) Management of smell and taste disorders. Thieme, Stuttgart, S 76–90

63.

Benninger MS et al (2004) Techniques of intranasal steroid use. Otolaryngol Head Neck Surg 130(1):5–24PubMed

64.

Sedaghat AR (2017) Chronic rhinosinusitis. Am Fam Physician 96(8):500–506PubMed

65.

Vent J, Wang DW, Damm M (2010) Effects of traditional Chinese acupuncture in post-viral olfactory dysfunction. Otolaryngol Head Neck Surg 142(4):505–509PubMed

66.

Drews T et al (2021) Acupuncture is associated with a positive effect on odour discrimination in patients with postinfectious smell loss—a controlled prospective study. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-021-06872-9CrossRefPubMed

67.

Hummel T et al (2017) Intranasal vitamin A is beneficial in post-infectious olfactory loss. Eur Arch Otorhinolaryngol 274(7):2819–2825PubMed

68.

Mori E et al (2016) The administration of nasal drops in the “Kaiteki” position allows for delivery of the drug to the olfactory cleft: a pilot study in healthy subjects. Eur Arch Otorhinolaryngol 273(4):939–943PubMed

69.

Whitcroft KL et al (2016) Intranasal sodium citrate solution improves olfaction in post-viral hyposmia. Rhinology 54(4):368–374PubMed

70.

Philpott CM et al (2017) A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders. Clin Otolaryngol 42(6):1295–1302PubMed

71.

Whitcroft KL et al (2017) The effect of intranasal sodium citrate on olfaction in post-infectious loss: results from a prospective, placebo-controlled trial in 49 patients. Clin Otolaryngol 42(3):557–563PubMed

72.

Whitcroft KL et al (2021) Intranasal sodium citrate in quantitative and qualitative olfactory dysfunction: results from a prospective, controlled trial of prolonged use in 60 patients. Eur Arch Otorhinolaryngol 278(8):2891–2897PubMedPubMedCentral

73.

Hummel T, Heilmann S, Huttenbriuk KB (2002) Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract. Laryngoscope 112(11):2076–2080PubMed

74.

Yan CH, Mundy DC, Patel ZM (2020) The use of platelet-rich plasma in treatment of olfactory dysfunction: a pilot study. Laryngoscope Investig Otolaryngol 5(2):187–193PubMedPubMedCentral

75.

Schöpf V et al (2015) Intranasal insulin influences the olfactory performance of patients with smell loss, dependent on the body mass index: a pilot study. Rhinology 53(4):371–378PubMed

76.

Rezaeian A (2018) Effect of intranasal insulin on olfactory recovery in patients with hyposmia: a randomized clinical trial. Otolaryngol Head Neck Surg 158(6):1134–1139PubMed

77.

Mohamad SA, Badawi AM, Mansour HF (2021) Insulin fast-dissolving film for intranasal delivery via olfactory region, a promising approach for the treatment of anosmia in COVID-19 patients: design, in-vitro characterization and clinical evaluation. Int J Pharm 601:120600PubMed

78.

Carrie I et al (2009) PUFA for prevention and treatment of dementia? Curr Pharm Des 15(36):4173–4185PubMed

79.

Yan CH et al (2020) Effect of omega‑3 supplementation in patients with smell dysfunction following endoscopic sellar and parasellar tumor resection: a multicenter prospective randomized controlled trial. Neurosurgery 87(2):E91–e98PubMedPubMedCentral

80.

Schubert CR et al (2013) Association of exercise with lower long-term risk of olfactory impairment in older adults. JAMA Otolaryngol Head Neck Surg 139(10):1061–1066PubMed

81.

Sollai G, Crnjar R (2021) Age-related olfactory decline is associated with levels of exercise and non-exercise physical activities. Front Aging Neurosci 13:695115PubMedPubMedCentral

82.

Dörig P et al (2021) Future therapeutic strategies for olfactory disorders: electrical stimulation, stem cell therapy, and transplantation of olfactory epithelium—an overview. HNO 69(8):623–632PubMed

Titel: Riech- und Schmeckstörungen
verfasst von: Dr. med. M. M. Speth
U. S. Speth
A. R. Sedaghat
T. Hummel
Publikationsdatum: 12.01.2022
Verlag: Springer Medizin
Schlagwörter: Neurologische Beteiligung bei Infektionserkrankungen
Riechstörungen
Rhinosinusitis
COVID-19
Riechstörungen
Schmeckstörung
Anosmie
Erschienen in: HNO / Ausgabe 2/2022
Print ISSN: 0017-6192
Elektronische ISSN: 1433-0458
DOI: https://doi.org/10.1007/s00106-021-01132-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Riech- und Schmeckstörungen

Zusammenfassung

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2022

Prognosefaktoren für das Gesamtüberleben bei Oropharynxkarzinomen in Abhängigkeit vom HPV-Status

Kritische Aspekte des transmandibulären Zugangswegs zu Mundhöhle und Oropharynx

Der Singing Voice Handicap Index-12

Definition und Darstellung der verschiedenen Typen des Nasenzyklus mittels Langzeitrhinometrie

Analyse von HNO-Notfallpatienten während der COVID-19-Pandemie in Deutschland

Vorbereitung zur Facharztprüfung HNO

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin